FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4328104953> ?p ?o ?g. }

• W4328104953 endingPage "97" @default.
• W4328104953 startingPage "85" @default.
• W4328104953 abstract "The therapeutic effects of photothermal therapy (PTT) are dependent on the photothermal conversion efficiency of photothermal agents (PTAs) in tumors and the subsequent activation of the antitumor immune system. However, the insufficient tumor accumulation of current PTAs and the inevitable recruitment of tumor-associated macrophages (TAMs) could further compromise the antitumor activities of PTT. To address these issues, a biomimetic photothermal nanoplatform Au@Fe-PM is developed for the targeted remodeling of TAMs, which promotes the antitumor immunity of PTT. Au nanorods with second near-infrared (NIR-II) absorptions are fabricated to serve as PTAs to induce immunogenic cell death in tumor cells. The ferric hydroxide shell coated on Au nanorods can release iron ions to repolarize M2-like TAMs into the tumoricidal M1 phenotype via P38 and STAT1-mediated signaling pathways. Moreover, the surface decoration of platelet membranes endows biomimetic nanoplatform with enhanced tumor targeting ability for precise tumor ablation and TAM regulation. Consequently, Au@Fe-PM under NIR-II laser irradiation exhibits significantly higher inhibitory effects in a poor immunogenic 4T1 tumor-bearing mouse model with a 50% complete remission rate compared to conventional PTT (0%). By simultaneously reversing the immunosuppressive tumor microenvironment, this biomimetic nanoplatform offers a promising strategy for enhancing the antitumor efficacy of PTT. STATEMENT OF SIGNIFICANCE: The therapeutic effects of current photothermal therapy (PTT) are hindered by the insufficient tumor accumulation of conventional photothermal agents and the recruitment of immunosuppressive tumor-associated macrophages (TAMs) after PTT. Herein, we report a biomimetic iron-based second near-infrared (NIR-II) photothermal nanoplatform (Au@Fe-PM) for targeted TAMs reprogramming and NIR-II mediated anti-tumor immunity. Au@Fe-PM can actively target the tumor site with the help of surface-decorated platelet membranes. Meanwhile, iron ions would be released from Au@Fe-PM in acidic lysosomes to reprogram TAMs into tumoricidal M1-like macrophages, which promotes the antitumor responses elicited by NIR-II PTT, thereby contributing to remarkable tumor inhibitory effects, with 50% higher complete remission rate than that of conventional PTT." @default.
• W4328104953 created "2023-03-22" @default.
• W4328104953 creator A5024421837 @default.
• W4328104953 creator A5040597182 @default.
• W4328104953 creator A5040946407 @default.
• W4328104953 creator A5043340013 @default.
• W4328104953 creator A5050900684 @default.
• W4328104953 creator A5064324932 @default.
• W4328104953 creator A5076972878 @default.
• W4328104953 creator A5083725221 @default.
• W4328104953 date "2023-05-01" @default.
• W4328104953 modified "2023-10-14" @default.
• W4328104953 title "A biomimetic nanoplatform for precise reprogramming of tumor-associated macrophages and NIR-II mediated antitumor immune activation" @default.
• W4328104953 cites W1999327728 @default.
• W4328104953 cites W2063470712 @default.
• W4328104953 cites W2081810806 @default.
• W4328104953 cites W2087168289 @default.
• W4328104953 cites W2102869104 @default.
• W4328104953 cites W2105585353 @default.
• W4328104953 cites W2291205197 @default.
• W4328104953 cites W2292446759 @default.
• W4328104953 cites W2427645657 @default.
• W4328104953 cites W2508374004 @default.
• W4328104953 cites W2525019996 @default.
• W4328104953 cites W2525790243 @default.
• W4328104953 cites W2536322725 @default.
• W4328104953 cites W2582686270 @default.
• W4328104953 cites W2609512644 @default.
• W4328104953 cites W2612920785 @default.
• W4328104953 cites W2744279836 @default.
• W4328104953 cites W2746715991 @default.
• W4328104953 cites W2794683780 @default.
• W4328104953 cites W2804669050 @default.
• W4328104953 cites W2893450414 @default.
• W4328104953 cites W2898415660 @default.
• W4328104953 cites W2899044337 @default.
• W4328104953 cites W2901221545 @default.
• W4328104953 cites W2902979010 @default.
• W4328104953 cites W2914311347 @default.
• W4328104953 cites W2926629367 @default.
• W4328104953 cites W2934131312 @default.
• W4328104953 cites W2945953423 @default.
• W4328104953 cites W2953815802 @default.
• W4328104953 cites W2971866769 @default.
• W4328104953 cites W2976182269 @default.
• W4328104953 cites W2989703847 @default.
• W4328104953 cites W3014461065 @default.
• W4328104953 cites W3015313279 @default.
• W4328104953 cites W3028666482 @default.
• W4328104953 cites W3035863374 @default.
• W4328104953 cites W3044858173 @default.
• W4328104953 cites W3082270296 @default.
• W4328104953 cites W3108735200 @default.
• W4328104953 cites W3161317876 @default.
• W4328104953 cites W3176085841 @default.
• W4328104953 cites W3196687122 @default.
• W4328104953 cites W3198379814 @default.
• W4328104953 cites W3208892929 @default.
• W4328104953 cites W4210363762 @default.
• W4328104953 cites W4213196375 @default.
• W4328104953 cites W4280492369 @default.
• W4328104953 cites W4292641413 @default.
• W4328104953 cites W4311138236 @default.
• W4328104953 doi "https://doi.org/10.1016/j.actbio.2023.03.021" @default.
• W4328104953 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36948328" @default.
• W4328104953 hasPublicationYear "2023" @default.
• W4328104953 type Work @default.
• W4328104953 citedByCount "0" @default.
• W4328104953 crossrefType "journal-article" @default.
• W4328104953 hasAuthorship W4328104953A5024421837 @default.
• W4328104953 hasAuthorship W4328104953A5040597182 @default.
• W4328104953 hasAuthorship W4328104953A5040946407 @default.
• W4328104953 hasAuthorship W4328104953A5043340013 @default.
• W4328104953 hasAuthorship W4328104953A5050900684 @default.
• W4328104953 hasAuthorship W4328104953A5064324932 @default.
• W4328104953 hasAuthorship W4328104953A5076972878 @default.
• W4328104953 hasAuthorship W4328104953A5083725221 @default.
• W4328104953 hasConcept C126201875 @default.
• W4328104953 hasConcept C155672457 @default.
• W4328104953 hasConcept C171250308 @default.
• W4328104953 hasConcept C182606246 @default.
• W4328104953 hasConcept C192562407 @default.
• W4328104953 hasConcept C203014093 @default.
• W4328104953 hasConcept C2776107976 @default.
• W4328104953 hasConcept C2777742735 @default.
• W4328104953 hasConcept C33197981 @default.
• W4328104953 hasConcept C502942594 @default.
• W4328104953 hasConcept C71924100 @default.
• W4328104953 hasConcept C8891405 @default.
• W4328104953 hasConceptScore W4328104953C126201875 @default.
• W4328104953 hasConceptScore W4328104953C155672457 @default.
• W4328104953 hasConceptScore W4328104953C171250308 @default.
• W4328104953 hasConceptScore W4328104953C182606246 @default.
• W4328104953 hasConceptScore W4328104953C192562407 @default.
• W4328104953 hasConceptScore W4328104953C203014093 @default.
• W4328104953 hasConceptScore W4328104953C2776107976 @default.
• W4328104953 hasConceptScore W4328104953C2777742735 @default.
• W4328104953 hasConceptScore W4328104953C33197981 @default.

• next